DHG Pharmaceutical JSC 2015 SR
The report highlights DHG Pharma's commitment to sustainable development in 2015, focusing on restructuring its management system and distribution network. Key achievements include the completion of the GMP-WHO Beta lactam plant and maintaining a strong domestic market presence across all 63 provinces in Vietnam. The company reported net sales of VND 3,608 billion and a profit after tax of VND 593 billion. Environmental initiatives led to significant energy savings, while social efforts included providing jobs for 2,876 employees and conducting 138 free medical care programs. The report follows GRI G4 standards and emphasizes core values of quality, safety, and community benefit.
Company: DHG Pharmaceutical JSC
Sector: Manufacturing
Country: Vietnam
Year: 2015
Type: SR
Pages: 53
DHG Pharmaceutical JSC
The report highlights DHG Pharma's commitment to sustainable development in 2015, focusing on restructuring its management system and distribution network. Key achievements include the completion of the GMP-WHO Beta lactam plant and maintaining a strong domestic market presence across all 63 provinces in Vietnam. The company reported net sales of VND 3,608 billion and a profit after tax of VND 593 billion. Environmental initiatives led to significant energy savings, while social efforts included providing jobs for 2,876 employees and conducting 138 free medical care programs. The report follows GRI G4 standards and emphasizes core values of quality, safety, and community benefit.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Women in Management
Workplace Fatalities
Employees